Benzo [c] benzopyrone derivative and application thereof
A technology of benzopyrone and benzopyran, which is applied in the field of benzo[c]benzopyrone derivatives and their application in the treatment of cancer diseases, and achieves the effect of obvious proliferation inhibition
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0035] The features and advantages of the present invention can be further understood through the following detailed description in conjunction with the accompanying drawings. The examples provided are only illustrative of the method of the present invention and do not limit the rest of the present disclosure in any way. [Example 1] Preparation of 3-(3-(4-methylpiperazin-1-yl)-propyl)-6H-benzo[c]benzopyran-6-one (BH1901)
[0036] Reaction 1
[0037]
[0038] 1) Synthesis of intermediates: Weigh urolithin B (20.2g), 1,3-dibromopropane (40.4g) and potassium carbonate (27.6g) in sequence in a 500mL round bottom flask, using acetone (200mL) as solvent , 50 ° C heating reaction 2h. Thin-layer chromatography (TLC) monitors, and the reaction can be stopped after the light blue raw material fluorescent spots disappear. Spin dry the system, dissolve the solid powder with petroleum ether, and spin dry again. Using silica gel as the stationary phase, it was eluted with petroleum e...
Embodiment 2
[0042] [Example 2] Preparation of 3-(3-morpholin-1-yl)-propyl)-6H-benzo[c]benzopyran-6-one (BH1902)
[0043] Replace 4-methylpiperazine with morpholine, and prepare the target compound according to the method of Example 1. White crystals were obtained. like figure 2 shown. 1H NMR (400MHz, DMSO-d6) δ8.29(d, J=8.1Hz, 1H, Ar-H), 8.25~8.15(m, 2H, Ar-H), 7.89(t, J=7.6Hz, 1H ,Ar-H),7.58(t,J=7.5Hz,1H,Ar-H),6.97(dd,J=4.5,2.2Hz,2H,Ar-H),4.10(t,J=6.3Hz,2H , O-CH2), 3.57(t, J=4.4Hz, 4H, -CH2-O-CH2), 2.41(dd, J=18.6, 11.4Hz, 6H, N-CH2), 1.90(p, J=6.6 Hz, 2H, -CH2)., Anal. Calcd for C20H21O4N, ESI-MS: 339.38 [M+H]+.
Embodiment 3
[0044] [Example 3] Preparation of 3-(3-(4-methylpiperidin-1-yl)-propyl)-6H-benzo[c]benzopyran-6-one (BH1903)
[0045] Replace 4-methylpiperazine with 4-methylpiperidine, and prepare the target compound according to the method of Example 1. Yellow crystals were obtained. like image 3 shown. 1H NMR (400MHz, DMSO-d6) δ8.17~8.27(m, 3H, Ar-H), 7.87(t, J=7.5Hz, 1H, Ar-H), 7.56(t, J=7.5Hz, 1H ,Ar-H),6.93(d,J=6.8Hz,2H,Ar-H),4.06(t,J=5.8Hz,2H,-O-CH2-),2.81(d,J=10.9Hz,2H ), 2.39(t, J=6.9Hz, 2H, -CH2-), 1.84(t, J=9.6Hz, 4H, -CH2-), 1.54(d, J=12.0Hz, 2H, -CH2-), 1.27(s,1H,-CH-),1.11(dd,J=22.1,10.6Hz,2H,-CH2-),0.85(d,J=6.2Hz,3H,-CH3), Anal.Calcd for C22H25O3N, ESI-MS: 351.44 [M+H]+.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com